AUDIO: 2020 has been a year that has delivered the world many challenges, the equilibrium has shifted and so many things are no longer as they should be. The Pharmaceutical Industry, like many others, has had to adjust to a “New Norm”
WHITEPAPER: When biotech and pharma companies transport investigational medical products (IMPs) internationally, they are often required to pay import
WHITEPAPER: A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes. A good
WHITEPAPER: In response to COVID-19, clinical trial sponsors are looking to site-to-patient transfers as a viable method to deliver medicines to patie
AUDIO: Asia Pacific is a growing destination for conducting cost-effective clinical trials – between 2007 and 2018 trials in Asia constituted around 2
AUDIO: Asia Pacific is a growing destination for conducting cost-effective clinical trials – between 2007 and 2018 trials in Asia constituted around 28.5% of all registered clinical trials globally
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients